Trial Profile
An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Nov 2005
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 22 Nov 2005 New trial record.